US drug regulator proposes social media guidelines for drug and medical device industryBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g4135 (Published 19 June 2014) Cite this as: BMJ 2014;348:g4135
- Michael McCarthy
The US Food and Drug Administration has issued draft guidelines for drug and medical device companies to use when posting information about products on internet platforms with strict limits on the number of characters allowed.1
Such platforms would include the microblogging site Twitter, which limits posts to 140 characters, and the sponsored links that appear with Google and Yahoo search results.
In the case of drugs, for example, the FDA said that such posts should include the brand and chemical name of the drug, and, if the post makes a claim of benefit, must also present the drug’s most serious risks.
The presentation of risks and benefits should be balanced and should be included in the same message, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial